Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Bill Beasley +1-240-753-6465
restore@agnovos.com


Study Location:

Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Recruiting

Open to: FEMALE

Age: 65.0 - N/A

Medical Conditions

Osteoporosis
Fractures, Bone
Hip Fractures


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Apr 2021 Apr 2027

INTERVENTIONAL

Intervention Type : DEVICE
Intervention Description : the implantation site is injected with the AGN1 implant material

Intervention Arm Group : Treated group;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Royal Infirmary of Edinburgh
    Edinburgh
    Scotland
  • Leicester Royal Infirmary
    Leicester
    England
  • Nottingham University Hospitals, Queen's Medical Center
    Nottingham
  • Birmingham Heartlands Hospital
    Birmingham
    England


The study is sponsored by AgNovos Healthcare, LLC and is in collaboration with Avania; CMIC Co, Ltd. Japan; BioClinica, Inc.; Emergent Clinical Consulting, LLC.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT04796350
Last updated 12 July 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.